“…Specifically, they may involve reduced biotransformation of organic nitrates to NO ⅐ , physiological counterregulatory mechanisms (eg, neurohormonal activation), desensitization of sGC, increased activity of phosphodiesterase 1A1, and increased production of reactive oxygen species leading to scavenging of NO ⅐ and a decreased bioavailability. 14,15 Given that HNO donors, such as AS, spontaneously donate HNO via a process that does not require biotransformation and are not susceptible to scavenging by superoxide, we hypothesize that tolerance will not develop to this class of nitrovasodilator. Conversely we predict that HNO donors may induce cross-tolerance to organic nitrates, given the ability of HNO to inhibit aldehyde dehydrogenase (ALDH), 16,17 an enzyme that has been implicated recently in the biotransformation of GTN in the vasculature.…”